Market Access Transformation, a Genesis Research company
Robert Hutcheson, MSc, PMP has a diverse work experience spanning over several roles and industries. Robert is currently working at Market Access Transformation as an Associate Director of Market Access Operations. Prior to this role, they were a Senior Consultant at the same company.
Before joining Market Access Transformation, Robert worked at Certara Evidence & Access for several years. Robert held the positions of Senior Manager, Manager, and Senior Analyst during their tenure.
Robert's earlier experience includes working at IC Axon, where they served as a Senior Medical Editor, Medical Editor, Senior Medical Writer, and Medical Writer. Robert also worked as a Laboratory Researcher and Teaching Assistant in the Biology Department at McGill University.
Overall, Robert has a strong background in market access operations and medical writing/editing, complemented by their experience in research and teaching within the biology field.
Robert Hutcheson, MSc, PMP completed their Master's of Science degree in Biology, with a focus on Neurobiology, at McGill University from 2004 to 2005. In addition to their academic qualifications, they also obtained the certifications of Certified Market Access Professional from the Canadian Association for Healthcare Reimbursement in May 2020, and Project Management Professional (PMP) from the Project Management Institute in December 2017.
This person is not in any offices
Market Access Transformation, a Genesis Research company
**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers